Quantcast

Latest Attention-deficit hyperactivity disorder management Stories

2014-06-17 12:32:12

Radiological Society of North America Brain iron levels offer a potential biomarker in the diagnosis of attention deficit hyperactivity disorder (ADHD) and may help physicians and parents make better informed treatment decisions, according to new research published online in the journal Radiology. ADHD is a common disorder in children and adolescents that can continue into adulthood. Symptoms include hyperactivity and difficulty staying focused, paying attention and controlling...

2014-06-16 23:00:10

Brain iron levels offer a potential biomarker in the diagnosis of attention deficit hyperactivity disorder (ADHD) and may help physicians and parents make better informed treatment decisions, according to new research published online, June 17, in the journal Radiology. Oak Brook, IL (PRWEB) June 16, 2014 Brain iron levels offer a potential biomarker in the diagnosis of attention deficit hyperactivity disorder (ADHD) and may help physicians and parents make better informed treatment...

2014-05-20 23:17:47

The Centers for Disease Control (CDC) recently announced that over 10,000 children ages 2 and 3 are taking amphetamine medications for ADD or ADHD. Should a rational parent, pediatrician, child psychiatrist or psychologist be alarmed by this statistic? Lexington, KY (PRWEB) May 20, 2014 In his May 16, 2014 article from the New York Times Alan Schwarz cited a recent government announcement that over 10,000 children ages 2 and 3 are being prescribed amphetamines for attention deficit...

2014-05-13 11:38:16

Duke University Medical Center Treating attention deficit hyperactivity disorder (ADHD) with stimulant medication may reduce smoking risk, especially when medication is taken consistently, according to an analysis led by researchers at Duke Medicine. The findings appear online May 12, 2014, in the journal Pediatrics. "Given that individuals with ADHD are more likely to smoke, our study supports the use of stimulant treatment to reduce the likelihood of smoking in youth with ADHD,"...

2014-05-09 13:39:44

Initiate PR Data presented at Society of Biological Psychiatry 69th Annual Scientific Meeting; lays groundwork for EB-1020 SR as a potential treatment option for adult ADHD Neurovance, Inc. today announced complete results from its phase 2a pilot study of EB-1020 SR, a non-stimulant, in adult male patients with all subtypes of ADHD (attention deficit hyperactivity disorder). EB-1020 SR is a norepinephrine- and dopamine-preferring triple reuptake inhibitor. The data showed a...

2014-05-07 09:34:02

Children with attention-deficit/hyperactivity disorder experienced more adversities than those without ADHD When children struggle with focusing on tasks, staying organized, controlling their behavior and sitting still, they may be evaluated for attention-deficit/hyperactivity disorder (ADHD). Clinicians, however, shouldn't stop there, according to a study to be presented Tuesday, May 6, at the Pediatric Academic Societies (PAS) annual meeting in Vancouver, British Columbia, Canada....

2014-04-28 08:32:18

TORONTO, April 28, 2014 /PRNewswire/ - Highland Therapeutics Inc. ("Highland"), an emerging pharmaceutical company, today announced that its wholly owned subsidiary has begun enrolment in a Phase III study of HLD-200, the Company's novel formulation of methylphenidate, in pediatric patients with Attention-Deficit Hyperactivity Disorder ("ADHD"). The study, "A Phase III Clinical Endpoint Evaluation Study ("CEES") Examining the Safety and Efficacy of HLD-200 in Pediatric Subjects with...

One In 13 Schoolchildren Take Medication For Behavioral Disorders
2014-04-25 10:00:05

Lawrence LeBlond for redOrbit.com - Your Universe Online According to a new government report, one in 13 US schoolchildren is taking at least one medication for emotional or behavioral disorders and more than half of the parents of these children maintain that the drugs used are actually working for their kids. The report is released by the National Center for Health Statistics (NCHS), a research arm of the US Centers for Disease Control and Prevention (CDC). "We can't advise parents...

2014-04-08 12:31:35

MIAMI, April 8, 2014 /PRNewswire-USNewswire/ -- Balancing a low dose of behavior therapy with a low dose of medication may be the key to helping children with Attention Deficit Hyperactivity Disorder (ADHD), according to a new study by researchers at FIU's Center for Children and Families. High doses of stimulant medication and intensive behavior therapy are each known to be effective individual modes of treatment. But medication may suppress a child's growth and decrease their...

2014-04-07 23:26:22

New supplement by Nature Optimized aims to naturally heal ADHD and the addictive brain. Spanish Fork, UT (PRWEB) April 07, 2014 Filling a much-needed gap in the ADHD supplement market, Nature Optimized makes liquid supplements with a unique, proprietary blend of fats and amino acids plus brain-supporting vitamins and minerals that is safe for children as well as pregnant women. The first formula, Pure Clarity Calm, increases focus and motivation while calming the active mind. The second...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related